{"transactions":[{"id":685666,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-17T22:40:43.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":65000,"derivative":{"exercise_price":43.56,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001853529-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000003/primarydocument.xml","form_type":"4/A","original_submission_date":"2026-08-14"}},{"id":687036,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":65000,"derivative":{"exercise_price":0,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":687035,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2027."}],"balance_after":32500,"derivative":{"exercise_price":0,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":687034,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":7031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":21094,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":7031},"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":687033,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025."}],"balance_after":11563,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":5781},"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":687032,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":390,"price":44.46,"value":17339.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."}],"balance_after":31466,"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":687031,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":2273,"price":43.6759,"value":99275.3207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.32 to $44.25, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":31856,"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":687030,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":3238,"price":43.6775,"value":141427.745,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.33 to $44.26, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34129,"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":687029,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":7031,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37367,"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":687028,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:53:51.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30336,"source":{"system":"sec-edgar","filing":"0001853529-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000002/primarydocument.xml","form_type":"4"}},{"id":718264,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T21:21:17.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":69648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest each month beginning on July 27, 2017, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":1077717,"derivative":{"exercise_price":0.18,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":69648},"source":{"system":"sec-edgar","filing":"0001853529-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000001/primarydocument.xml","form_type":"4"}},{"id":718263,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T21:21:17.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":130352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest each month beginning on September 10, 2018, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":0,"derivative":{"exercise_price":0.45,"expiration_date":"2028-08-30","underlying":"Common Stock","underlying_shares":130352},"source":{"system":"sec-edgar","filing":"0001853529-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000001/primarydocument.xml","form_type":"4"}},{"id":718262,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:21:17.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":69648,"price":39.4089,"value":2744751.0672,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $38.77 to $40.905, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":24555,"source":{"system":"sec-edgar","filing":"0001853529-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000001/primarydocument.xml","form_type":"4"}},{"id":718261,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:21:17.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":130352,"price":39.406,"value":5136650.912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $38.77 to $40.81, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":94203,"source":{"system":"sec-edgar","filing":"0001853529-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000001/primarydocument.xml","form_type":"4"}},{"id":718260,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:21:17.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":69648,"price":0.18,"value":12536.64,"ownership":{"direct":true},"balance_after":224555,"source":{"system":"sec-edgar","filing":"0001853529-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000001/primarydocument.xml","form_type":"4"}},{"id":718259,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:21:17.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":130352,"price":0.45,"value":58658.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 107 shares purchased on November 15, 2025 and 1,048 shares purchased on May 15, 2026 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":154907,"source":{"system":"sec-edgar","filing":"0001853529-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352926000001/primarydocument.xml","form_type":"4"}},{"id":1000397,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-13T23:06:38.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1147365,"derivative":{"exercise_price":0.18,"exercise_date":"2021-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001853529-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352925000007/primarydocument.xml","form_type":"4"}},{"id":1000396,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-13T23:06:38.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":21.1245,"value":2112450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.35, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23400,"source":{"system":"sec-edgar","filing":"0001853529-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352925000007/primarydocument.xml","form_type":"4"}},{"id":1000395,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-13T23:06:38.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":0.18,"value":18000.0,"ownership":{"direct":true},"balance_after":123400,"source":{"system":"sec-edgar","filing":"0001853529-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352925000007/primarydocument.xml","form_type":"4"}},{"id":1053699,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-28T20:55:53.000Z","date":"2025-08-26","kind":"exercise","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1247365,"derivative":{"exercise_price":0.18,"exercise_date":"2021-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001853529-25-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352925000003/primarydocument.xml","form_type":"4"}},{"id":1053698,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-28T20:55:53.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":14.5976,"value":1459760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.825, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23400,"source":{"system":"sec-edgar","filing":"0001853529-25-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352925000003/primarydocument.xml","form_type":"4"}},{"id":1053697,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-28T20:55:53.000Z","date":"2025-08-26","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":0.18,"value":18000.0,"ownership":{"direct":true},"balance_after":123400,"source":{"system":"sec-edgar","filing":"0001853529-25-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000185352925000003/primarydocument.xml","form_type":"4"}},{"id":1066636,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T23:42:38.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":168750,"derivative":{"exercise_price":13.39,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001562180-25-005796","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025005796/primarydocument.xml","form_type":"4"}},{"id":1066635,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T23:42:38.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":28125,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001562180-25-005796","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025005796/primarydocument.xml","form_type":"4"}},{"id":1066634,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T23:42:38.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":false,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025."}],"balance_after":17344,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":5781},"source":{"system":"sec-edgar","filing":"0001562180-25-005796","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025005796/primarydocument.xml","form_type":"4"}},{"id":1066633,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-14T23:42:38.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":1907,"price":13.3924,"value":25539.3068,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23400,"source":{"system":"sec-edgar","filing":"0001562180-25-005796","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025005796/primarydocument.xml","form_type":"4"}},{"id":1066632,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-08-14T23:42:38.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":true,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,005 shares purchased on May 15, 2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":25307,"source":{"system":"sec-edgar","filing":"0001562180-25-005796","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025005796/primarydocument.xml","form_type":"4"}},{"id":1156272,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-08T01:10:58.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":5209,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-05-01","expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":5209},"source":{"system":"sec-edgar","filing":"0001562180-25-003660","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025003660/primarydocument.xml","form_type":"4"}},{"id":1156271,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-08T01:10:58.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":1551,"price":16.4542,"value":25520.4642,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18521,"source":{"system":"sec-edgar","filing":"0001562180-25-003660","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025003660/primarydocument.xml","form_type":"4"}},{"id":1156270,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-08T01:10:58.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":5209,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20072,"source":{"system":"sec-edgar","filing":"0001562180-25-003660","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025003660/primarydocument.xml","form_type":"4"}},{"id":1212496,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:33:15.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Option was fully vested on June 27, 2021."}],"balance_after":1456580,"derivative":{"exercise_price":0.18,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001562180-25-002294","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025002294/primarydocument.xml","form_type":"4"}},{"id":1212495,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-11T20:33:15.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":200,"price":30.02,"value":6004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14863,"source":{"system":"sec-edgar","filing":"0001562180-25-002294","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025002294/primarydocument.xml","form_type":"4"}},{"id":1212494,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-11T20:33:15.000Z","date":"2025-03-07","kind":"exercise","planned":true,"acquired":true,"shares":200,"price":0.18,"value":36.0,"ownership":{"direct":true},"balance_after":15063,"source":{"system":"sec-edgar","filing":"0001562180-25-002294","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025002294/primarydocument.xml","form_type":"4"}},{"id":1278859,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:38:15.000Z","date":"2025-02-06","kind":"exercise","planned":true,"acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1347565,"derivative":{"exercise_price":0.18,"exercise_date":"2021-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001562180-25-001026","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025001026/primarydocument.xml","form_type":"4"}},{"id":1278858,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:38:15.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":false,"shares":8015,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1348765,"derivative":{"exercise_price":0.18,"exercise_date":"2021-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":8015},"source":{"system":"sec-edgar","filing":"0001562180-25-001026","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025001026/primarydocument.xml","form_type":"4"}},{"id":1278857,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-07T21:38:15.000Z","date":"2025-02-06","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":30.1275,"value":36153.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.22, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14863,"source":{"system":"sec-edgar","filing":"0001562180-25-001026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025001026/primarydocument.xml","form_type":"4"}},{"id":1278856,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-07T21:38:15.000Z","date":"2025-02-06","kind":"exercise","planned":true,"acquired":true,"shares":1200,"price":0.18,"value":216.0,"ownership":{"direct":true},"balance_after":16063,"source":{"system":"sec-edgar","filing":"0001562180-25-001026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025001026/primarydocument.xml","form_type":"4"}},{"id":1278855,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-07T21:38:15.000Z","date":"2025-02-05","kind":"sale","planned":true,"acquired":false,"shares":8015,"price":30.0216,"value":240623.124,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.0216, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14863,"source":{"system":"sec-edgar","filing":"0001562180-25-001026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025001026/primarydocument.xml","form_type":"4"}},{"id":1278854,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-07T21:38:15.000Z","date":"2025-02-05","kind":"exercise","planned":true,"acquired":true,"shares":8015,"price":0.18,"value":1442.7,"ownership":{"direct":true},"balance_after":22878,"source":{"system":"sec-edgar","filing":"0001562180-25-001026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218025001026/primarydocument.xml","form_type":"4"}},{"id":1319890,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-31T22:13:19.000Z","date":"2024-12-30","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vested each month after June 27, 2017."}],"balance_after":1356780,"derivative":{"exercise_price":0.18,"exercise_date":"2021-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-24-008663","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024008663/primarydocument.xml","form_type":"4"}},{"id":1319889,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-12-31T22:13:19.000Z","date":"2024-12-30","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":27.3747,"value":2737470.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $27.90, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14863,"source":{"system":"sec-edgar","filing":"0001562180-24-008663","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024008663/primarydocument.xml","form_type":"4"}},{"id":1319888,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-12-31T22:13:19.000Z","date":"2024-12-30","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":0.18,"value":18000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,144 shares purchased on November 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":114863,"source":{"system":"sec-edgar","filing":"0001562180-24-008663","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024008663/primarydocument.xml","form_type":"4"}},{"id":1400223,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-25T00:25:46.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vested each month beginning on June 27, 2017."}],"balance_after":1456780,"derivative":{"exercise_price":0.18,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001562180-24-006947","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024006947/primarydocument.xml","form_type":"4"}},{"id":1400222,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-25T00:25:46.000Z","date":"2024-09-20","kind":"sale","planned":false,"acquired":false,"shares":815,"price":29.5074,"value":24048.531,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.56, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12719,"source":{"system":"sec-edgar","filing":"0001562180-24-006947","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024006947/primarydocument.xml","form_type":"4"}},{"id":1400221,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-25T00:25:46.000Z","date":"2024-09-20","kind":"sale","planned":false,"acquired":false,"shares":74185,"price":28.2544,"value":2096052.664,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $28.02 to $28.47, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13534,"source":{"system":"sec-edgar","filing":"0001562180-24-006947","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024006947/primarydocument.xml","form_type":"4"}},{"id":1400220,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-25T00:25:46.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":true,"shares":75000,"price":0.18,"value":13500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,968 shares purchased on May 15, 2023, 2,088 shares purchased on November 15, 2023 and 425 shares purchased on May 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":87719,"source":{"system":"sec-edgar","filing":"0001562180-24-006947","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024006947/primarydocument.xml","form_type":"4"}},{"id":1433860,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-14T20:15:32.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":23125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2024."}],"balance_after":23125,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":23125},"source":{"system":"sec-edgar","filing":"0001562180-24-006261","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024006261/primarydocument.xml","form_type":"4"}},{"id":1433859,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T20:15:32.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":138750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on August 12, 2024, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":138750,"derivative":{"exercise_price":17.05,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":138750},"source":{"system":"sec-edgar","filing":"0001562180-24-006261","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024006261/primarydocument.xml","form_type":"4"}},{"id":1528598,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:28:24.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted to the reporting person which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":5209,"derivative":{"exercise_price":0,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":5208},"source":{"system":"sec-edgar","filing":"0001562180-24-003827","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024003827/primarydocument.xml","form_type":"4"}},{"id":1528597,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-03T22:28:24.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":1576,"price":18.91,"value":29802.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.68 to $19.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7238,"source":{"system":"sec-edgar","filing":"0001562180-24-003827","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024003827/primarydocument.xml","form_type":"4"}},{"id":1528596,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-03T22:28:24.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,968 shares purchased on May 15, 2023 and 2,088 shares purchased on November 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":8814,"source":{"system":"sec-edgar","filing":"0001562180-24-003827","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218024003827/primarydocument.xml","form_type":"4"}},{"id":1698807,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-12-28T21:38:37.000Z","date":"2023-12-26","kind":"sale","planned":false,"acquired":false,"shares":172585,"price":9.3293,"value":1610097.2405,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $9.155 USD to $9.595 USD; the price reported above reflects the weighted average sale price."}],"balance_after":3606,"source":{"system":"sec-edgar","filing":"0001562180-23-008571","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218023008571/primarydocument.xml","form_type":"4"}},{"id":1802045,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-18T23:13:22.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":200000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-23-006454","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218023006454/primarydocument.xml","form_type":"4"}},{"id":1906335,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-03T22:26:08.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted to the reporting person which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":10417,"derivative":{"exercise_price":0,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":5208},"source":{"system":"sec-edgar","filing":"0001562180-23-003920","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218023003920/primarydocument.xml","form_type":"4"}},{"id":1906334,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-05-03T22:26:08.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":1602,"price":8.9049,"value":14265.6498,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $8.59 to $9.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":176191,"source":{"system":"sec-edgar","filing":"0001562180-23-003920","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218023003920/primarydocument.xml","form_type":"4"}},{"id":1906333,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-05-03T22:26:08.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":177793,"source":{"system":"sec-edgar","filing":"0001562180-23-003920","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218023003920/primarydocument.xml","form_type":"4"}},{"id":2189673,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T21:42:42.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 8, 2022, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":220000,"derivative":{"exercise_price":10.39,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001562180-22-006029","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218022006029/primarydocument.xml","form_type":"4"}},{"id":2284582,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-03T20:14:26.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":15625,"derivative":{"exercise_price":0,"expiration_date":"2025-05-01","underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001562180-22-003664","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218022003664/primarydocument.xml","form_type":"4"}},{"id":2490770,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-01T23:20:14.000Z","date":"2021-11-30","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vested on September 10, 2018 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":130352,"derivative":{"exercise_price":0.45,"expiration_date":"2028-08-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-21-007369","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007369/primarydocument.xml","form_type":"4"}},{"id":2490769,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-01T23:20:14.000Z","date":"2021-11-30","kind":"exercise","acquired":false,"shares":147585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option vested on July 27, 2018 and 1/48th of the shares subject to the option vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.18,"expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":147585},"source":{"system":"sec-edgar","filing":"0001562180-21-007369","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007369/primarydocument.xml","form_type":"4"}},{"id":2490768,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-01T23:20:14.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":25000,"price":0.45,"value":11250.0,"ownership":{"direct":true},"balance_after":172585,"source":{"system":"sec-edgar","filing":"0001562180-21-007369","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007369/primarydocument.xml","form_type":"4"}},{"id":2490767,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-01T23:20:14.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":147585,"price":0.18,"value":26565.3,"ownership":{"direct":true},"balance_after":147585,"source":{"system":"sec-edgar","filing":"0001562180-21-007369","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007369/primarydocument.xml","form_type":"4"}},{"id":2507821,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-17T23:05:19.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":38,"price":19.61,"value":745.18,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-21-007134","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007134/primarydocument.xml","form_type":"4"}},{"id":2507820,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-17T23:05:19.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":441,"price":19.0708,"value":8410.2228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.56 to $19.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38,"source":{"system":"sec-edgar","filing":"0001562180-21-007134","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007134/primarydocument.xml","form_type":"4"}},{"id":2515506,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T22:24:09.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":8562,"price":19.5134,"value":167073.7308,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.89, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":479,"source":{"system":"sec-edgar","filing":"0001562180-21-007025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007025/primarydocument.xml","form_type":"4"}},{"id":2515505,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T22:24:09.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":3681,"price":20.428,"value":75195.468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.29 to $20.82, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9041,"source":{"system":"sec-edgar","filing":"0001562180-21-007025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007025/primarydocument.xml","form_type":"4"}},{"id":2515504,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T22:24:09.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":15595,"price":19.8168,"value":309042.996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.29 to $20.285, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12722,"source":{"system":"sec-edgar","filing":"0001562180-21-007025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007025/primarydocument.xml","form_type":"4"}},{"id":2515503,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T22:24:09.000Z","date":"2021-11-10","kind":"sale","acquired":false,"shares":580,"price":20.2122,"value":11723.076,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.16 to $20.35, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":28317,"source":{"system":"sec-edgar","filing":"0001562180-21-007025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007025/primarydocument.xml","form_type":"4"}},{"id":2515502,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T22:24:09.000Z","date":"2021-11-10","kind":"sale","acquired":false,"shares":11746,"price":19.7043,"value":231446.7078,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.095 to $20.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":28897,"source":{"system":"sec-edgar","filing":"0001562180-21-007025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007025/primarydocument.xml","form_type":"4"}},{"id":2515501,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T22:24:09.000Z","date":"2021-11-09","kind":"sale","acquired":false,"shares":12712,"price":20.2982,"value":258030.7184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.17 to $20.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":40643,"source":{"system":"sec-edgar","filing":"0001562180-21-007025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007025/primarydocument.xml","form_type":"4"}},{"id":2515500,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T22:24:09.000Z","date":"2021-11-09","kind":"sale","acquired":false,"shares":16864,"price":19.9404,"value":336274.9056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.17 to $20.165, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53355,"source":{"system":"sec-edgar","filing":"0001562180-21-007025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021007025/primarydocument.xml","form_type":"4"}},{"id":2521565,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-09T00:11:35.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":9017,"price":20.1646,"value":181824.1982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.84 to $20.645, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":70219,"source":{"system":"sec-edgar","filing":"0001562180-21-006901","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006901/primarydocument.xml","form_type":"4"}},{"id":2521564,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-09T00:11:35.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":13036,"price":19.6213,"value":255783.2668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $20.19, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":79236,"source":{"system":"sec-edgar","filing":"0001562180-21-006901","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006901/primarydocument.xml","form_type":"4"}},{"id":2521563,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-09T00:11:35.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":6,"price":20.7,"value":124.2,"ownership":{"direct":true},"balance_after":92272,"source":{"system":"sec-edgar","filing":"0001562180-21-006901","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006901/primarydocument.xml","form_type":"4"}},{"id":2521562,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-09T00:11:35.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":7392,"price":19.7635,"value":146091.792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.43 to $20.415, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":92278,"source":{"system":"sec-edgar","filing":"0001562180-21-006901","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006901/primarydocument.xml","form_type":"4"}},{"id":2526762,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-03T23:00:54.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":1119,"price":19.4154,"value":21725.8326,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.36 to $19.53, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":99670,"source":{"system":"sec-edgar","filing":"0001562180-21-006811","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006811/primarydocument.xml","form_type":"4"}},{"id":2526761,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-03T23:00:54.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":4243,"price":18.8415,"value":79944.4845,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.345 to $19.34, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100789,"source":{"system":"sec-edgar","filing":"0001562180-21-006811","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006811/primarydocument.xml","form_type":"4"}},{"id":2526760,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-03T23:00:54.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":20822,"price":17.9822,"value":374425.3684,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.325 to $18.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105032,"source":{"system":"sec-edgar","filing":"0001562180-21-006811","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006811/primarydocument.xml","form_type":"4"}},{"id":2526759,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-03T23:00:54.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":17519,"price":17.4302,"value":305359.6738,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.025 to $17.995, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":125854,"source":{"system":"sec-edgar","filing":"0001562180-21-006811","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006811/primarydocument.xml","form_type":"4"}},{"id":2526758,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-03T23:00:54.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":469,"price":18.0246,"value":8453.5374,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":143373,"source":{"system":"sec-edgar","filing":"0001562180-21-006811","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006811/primarydocument.xml","form_type":"4"}},{"id":2540734,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-18T23:48:19.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":126,"price":18,"value":2268.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."}],"balance_after":143842,"source":{"system":"sec-edgar","filing":"0001562180-21-006498","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006498/primarydocument.xml","form_type":"4"}},{"id":2540733,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-18T23:48:19.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":1307,"price":18.1317,"value":23698.1319,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":143968,"source":{"system":"sec-edgar","filing":"0001562180-21-006498","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006498/primarydocument.xml","form_type":"4"}},{"id":2540732,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-18T23:48:19.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":5749,"price":18.18,"value":104516.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.75, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":145275,"source":{"system":"sec-edgar","filing":"0001562180-21-006498","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006498/primarydocument.xml","form_type":"4"}},{"id":2543616,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-13T22:51:12.000Z","date":"2021-10-11","kind":"sale","acquired":false,"shares":1270,"price":18.02,"value":22885.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.18, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":151024,"source":{"system":"sec-edgar","filing":"0001562180-21-006455","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006455/primarydocument.xml","form_type":"4"}},{"id":2545625,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T22:00:35.000Z","date":"2021-10-08","kind":"sale","acquired":false,"shares":5902,"price":18.15,"value":107121.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152294,"source":{"system":"sec-edgar","filing":"0001562180-21-006391","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006391/primarydocument.xml","form_type":"4"}},{"id":2545624,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T22:00:35.000Z","date":"2021-10-07","kind":"sale","acquired":false,"shares":13018,"price":18.56,"value":241614.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.62, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":158196,"source":{"system":"sec-edgar","filing":"0001562180-21-006391","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006391/primarydocument.xml","form_type":"4"}},{"id":2545623,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T22:00:35.000Z","date":"2021-10-06","kind":"sale","acquired":false,"shares":2108,"price":18.03,"value":38007.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.22, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":171214,"source":{"system":"sec-edgar","filing":"0001562180-21-006391","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006391/primarydocument.xml","form_type":"4"}},{"id":2549477,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-05T22:33:47.000Z","date":"2021-10-05","kind":"sale","acquired":false,"shares":5404,"price":18.26,"value":98677.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.75, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":173322,"source":{"system":"sec-edgar","filing":"0001562180-21-006323","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006323/primarydocument.xml","form_type":"4"}},{"id":2549476,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-05T22:33:47.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":100,"price":18,"value":1800.0,"ownership":{"direct":true},"balance_after":178726,"source":{"system":"sec-edgar","filing":"0001562180-21-006323","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006323/primarydocument.xml","form_type":"4"}},{"id":2549475,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-05T22:33:47.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":274,"price":18,"value":4932.0,"ownership":{"direct":true},"balance_after":178826,"source":{"system":"sec-edgar","filing":"0001562180-21-006323","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006323/primarydocument.xml","form_type":"4"}},{"id":2555866,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-30T23:16:11.000Z","date":"2021-09-29","kind":"sale","acquired":false,"shares":618,"price":17.47,"value":10796.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.37 to $17.71, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":179100,"source":{"system":"sec-edgar","filing":"0001562180-21-006168","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006168/primarydocument.xml","form_type":"4"}},{"id":2555865,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-30T23:16:11.000Z","date":"2021-09-29","kind":"sale","acquired":false,"shares":11226,"price":16.83,"value":188933.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.36 to $17.36, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":179718,"source":{"system":"sec-edgar","filing":"0001562180-21-006168","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006168/primarydocument.xml","form_type":"4"}},{"id":2555864,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-30T23:16:11.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":14610,"price":17.3,"value":252753.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.985 to $17.93, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":190944,"source":{"system":"sec-edgar","filing":"0001562180-21-006168","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006168/primarydocument.xml","form_type":"4"}},{"id":2559007,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:32:39.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":17,"price":18.48,"value":314.16,"ownership":{"direct":true},"balance_after":205554,"source":{"system":"sec-edgar","filing":"0001562180-21-006116","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006116/primarydocument.xml","form_type":"4"}},{"id":2559006,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:32:39.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":11594,"price":17.98,"value":208460.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.47 to $18.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":205571,"source":{"system":"sec-edgar","filing":"0001562180-21-006116","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006116/primarydocument.xml","form_type":"4"}},{"id":2559005,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:32:39.000Z","date":"2021-09-24","kind":"sale","acquired":false,"shares":20100,"price":18.16,"value":365016.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.84 to $18.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":217165,"source":{"system":"sec-edgar","filing":"0001562180-21-006116","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006116/primarydocument.xml","form_type":"4"}},{"id":2559004,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:32:39.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":5072,"price":19.42,"value":98498.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.97. to $19.96, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":237265,"source":{"system":"sec-edgar","filing":"0001562180-21-006116","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006116/primarydocument.xml","form_type":"4"}},{"id":2559003,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:32:39.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":21763,"price":18.34,"value":399133.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $17.93 to $18.925, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":242337,"source":{"system":"sec-edgar","filing":"0001562180-21-006116","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021006116/primarydocument.xml","form_type":"4"}},{"id":2596354,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22917,"kind":"person","name":"Russell Alan J","position":1,"cik":"0001853529","reported_name":"Russell Alan J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-19T21:10:11.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":120000,"derivative":{"exercise_price":16.38,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001562180-21-005463","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853529/000156218021005463/primarydocument.xml","form_type":"4"}}]}